FI963611A - Diabeettisen munuaissairauden hoito valsartaanilla - Google Patents

Diabeettisen munuaissairauden hoito valsartaanilla Download PDF

Info

Publication number
FI963611A
FI963611A FI963611A FI963611A FI963611A FI 963611 A FI963611 A FI 963611A FI 963611 A FI963611 A FI 963611A FI 963611 A FI963611 A FI 963611A FI 963611 A FI963611 A FI 963611A
Authority
FI
Finland
Prior art keywords
valsartan
treatment
diabetic nephropathy
nephropathy
diabetic
Prior art date
Application number
FI963611A
Other languages
English (en)
Swedish (sv)
Other versions
FI963611A0 (fi
Inventor
Gasparo Marc De
Nigel Levens
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4195481&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963611(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI963611A0 publication Critical patent/FI963611A0/fi
Publication of FI963611A publication Critical patent/FI963611A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI963611A 1994-03-17 1996-09-13 Diabeettisen munuaissairauden hoito valsartaanilla FI963611A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH80094 1994-03-17
PCT/EP1995/000831 WO1995024901A1 (en) 1994-03-17 1995-03-07 Treatment of diabetic nephropathy with valsartan

Publications (2)

Publication Number Publication Date
FI963611A0 FI963611A0 (fi) 1996-09-13
FI963611A true FI963611A (fi) 1996-09-13

Family

ID=4195481

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963611A FI963611A (fi) 1994-03-17 1996-09-13 Diabeettisen munuaissairauden hoito valsartaanilla

Country Status (12)

Country Link
EP (1) EP0750500A1 (fi)
JP (1) JPH09510225A (fi)
CN (1) CN1143908A (fi)
AU (1) AU1850695A (fi)
BR (1) BR9507086A (fi)
CA (1) CA2184712A1 (fi)
CZ (1) CZ268896A3 (fi)
FI (1) FI963611A (fi)
HU (1) HUT76542A (fi)
PL (1) PL316259A1 (fi)
SK (1) SK117996A3 (fi)
WO (1) WO1995024901A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1791497A (en) * 1996-02-29 1997-09-16 Novartis Ag At1 receptor antagonist for the stimulation of apoptosis
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
WO1999012534A1 (fr) * 1997-09-10 1999-03-18 Ono Pharmaceutical Co., Ltd. Regulateurs des recepteurs actives par le proliferateur des peroxisomes
PT1096932E (pt) * 1998-07-10 2007-09-21 Novartis Pharma Ag ''combinação anti-hipertensiva de valsartan e bloqueadores do canal de cálcio''
US6465502B1 (en) * 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
JP2002533390A (ja) 1998-12-23 2002-10-08 ノバルティス アクチエンゲゼルシャフト Ａｔ−１またはａｔ−２レセプターの増加に関連する疾患の処置のための、ａｔ−１レセプターアンタゴニストまたはａｔ−２レセプターモジュレーターの使用
CZ20024180A3 (cs) * 2000-06-22 2003-04-16 Novartis Ag Pevné orální farmaceutické kompozice obsahující valsartan
JP4102664B2 (ja) 2000-07-19 2008-06-18 ノバルティス アクチエンゲゼルシャフト バルサルタン塩
AR033390A1 (es) * 2000-08-22 2003-12-17 Novartis Ag Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
US20060089389A1 (en) 2000-08-22 2006-04-27 Malcolm Allison Combination
EG24716A (en) 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
EP1454625A1 (en) * 2003-03-06 2004-09-08 Speedel Development AG Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
CA2544747A1 (en) * 2003-11-14 2005-05-26 Novartis Ag At1-receptor antagonists for treating nephrotic syndrome
TR200703568A1 (tr) 2007-05-24 2008-07-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Valsartan formülasyonları
EP2405899A2 (en) 2009-03-11 2012-01-18 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Valsartan formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
DE122007000050I1 (de) * 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
US5140037A (en) * 1990-03-20 1992-08-18 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
GB9027210D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
ZA931063B (en) * 1992-02-17 1993-09-23 Ciba Geigy Treatment of glaucoma.

Also Published As

Publication number Publication date
FI963611A0 (fi) 1996-09-13
SK117996A3 (en) 1997-03-05
CA2184712A1 (en) 1995-09-21
WO1995024901A1 (en) 1995-09-21
CN1143908A (zh) 1997-02-26
PL316259A1 (en) 1997-01-06
CZ268896A3 (en) 1997-03-12
JPH09510225A (ja) 1997-10-14
BR9507086A (pt) 1997-09-16
MX9603999A (es) 1997-12-31
AU1850695A (en) 1995-10-03
HU9602536D0 (en) 1996-11-28
EP0750500A1 (en) 1997-01-02
HUT76542A (en) 1997-09-29

Similar Documents

Publication Publication Date Title
NO963777D0 (no) Kateter med aksel av varierende stivhet
FI970357A (fi) Tyypin II diabeteksen hoitoon käyttökelpoisia bensoksatsoli- ja pyridiinijohdannaisia
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
FI963611A (fi) Diabeettisen munuaissairauden hoito valsartaanilla
PL329851A1 (en) Treatment of diseases associated with vegf
PL315666A1 (en) Heterocyclic compounds of therapeutic properties
FI933331A (fi) Menetelmä vesiliukoisen ravintokuidun käsittelemiseksi beetta-glukanaasilla
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO975718L (no) Behandling av insulinresistens
DE69837089D1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
ATE366577T1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
NO963869D0 (no) Behandling av diabetisk nefropati med valsartan
FI971317A (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
GB9824160D0 (en) Heterocyclic compounds and their therapeutic use
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO20022244D0 (no) Behandling av SLE med dehydroepiandrosteron
FI951494A0 (fi) Jyvien käsittely laajentimella
KR950026706U (ko) 치료용 발열기
NO20000274D0 (no) Behandling av fluider
KR950008161U (ko) 개인용 찜질사우나
NO962971D0 (no) Rullestol med gir
UA25399A (uk) Спосіб лікуваhhя хворих гломерулоhефритом
KR960021252U (ko) 토오크리미터 내장형 감속기
KR960014504U (ko) 하수 처리용 원심 분리기